Thomas Craig Benson

Former President, Private Equity Division at Service Corp. International

Thomas Craig Benson

Thomas Craig Benson

Former President, Private Equity Division at Service Corp. International

Overview
Career Highlights

Investment Capital Corp.
SCI International, Inc.
Rules-Based Medicine, Inc.

RelSci Relationships

474

Number of Boards

12

Birthday

1963

Age

56

Relationships
RelSci Relationships are individuals Thomas Craig Benson likely has professional access to. A relationship does not necessarily indicate a personal connection.

Former Chief Executive Officer at Biophysical Corp.

Relationship likelihood: Strong

Former Chief Medical Officer & Vice President-Clinical Affairs at Luminex Corp.

Relationship likelihood: Strong

President & Chief Executive Officer at Myriad Genetics, Inc.

Relationship likelihood: Strong

Research Team Leader at Friess Associates LLC

Relationship likelihood: Strong

Sales Manager/Member at Johnson Rice & Co. LLC

Relationship likelihood: Strong

Member, Board of Directors at Biophysical Corp.

Relationship likelihood: Strong

Former Vice President-Patient Advocacy at Audentes Therapeutics, Inc.

Relationship likelihood: Strong

Member at Large, Board of Directors at Batten Disease Support and Research Association

Relationship likelihood: Strong

Member at Large, Board of Directors at Batten Disease Support and Research Association

Relationship likelihood: Strong

Member at Large, Board of Directors at Batten Disease Support and Research Association

Relationship likelihood: Strong

Paths to Thomas Craig Benson
Potential Connections via
Relationship Science
You
Thomas Craig Benson
Former President, Private Equity Division at Service Corp. International
Family Members
Education
Bachelor of Business Administration
Class of 1984
Career History
Chief Executive Officer
2011 - Prior

Myriad RBM, Inc. provides protein biomarker products and services. Its biomarker testing service provides pre-clinical and clinical researchers with reproducible, quantitative, multiplexed immunoassay data for hundreds of proteins in a cost-effective manner, from a small sample volume and from multiple species. The company was founded in 1998 and is headquartered in Salt Lake City, UT.

President, Myriad RBM, Inc
2011 - Prior

Our goal, at Myriad, is to make a difference in patient’s lives and for the past twenty years, the Company’s strategy has been guided by this mission. To accomplish this, we are focused on revolutionizing patient care through the development and marketing of transformative tests which address pressing clinical needs across multiple medical specialties. Over the last twenty years, Myriad has invested heavily in the education of patients and health care providers on the role genes and their related proteins play in disease. Almost one million patients have already benefited from Myriad’s informative testing, which helps physicians better manage their health care. Today, Myriad continues to build on this strong tradition. We are working to expand our reach by introducing new genetic tests and molecular diagnostic tests for a number of diseases. We also are focused on extending our mission internationally, in an effort to broaden our geographic footprint and provide critical information to more patients and healthcare providers

President
1990 - 1994
Boards & Committees
Director
Current
Non-Executive Director
2008 - Prior
Member, Board of Directors
2002 - 2011
Political Donations
$1,000
2012
$2,500
2011
$2,000
2009
Transactions
Details Hidden

Myriad Genetics, Inc. purchases Rules-Based Medicine, Inc. from Equity Group Investments LLC, Cross Creek Advisors LLC, Stephens Capital Partners LLC

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Thomas Craig Benson. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Thomas Craig Benson's profile does not indicate a business or promotional relationship of any kind between RelSci and Thomas Craig Benson.